|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
acetophenazine binds to and results in decreased activity of AR protein |
CTD |
PMID:17606915 |
|
NCBI chr X:63,104,771...63,273,934
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
ISO |
Indinavir results in decreased activity of ABCB11 protein Indinavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 PMID:28437613 |
|
NCBI chr 3:74,424,620...74,520,646
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
Indinavir inhibits the reaction [Celecoxib results in increased activity of ACHE protein]; Indinavir inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:18343489 |
|
NCBI chr12:25,042,882...25,050,608
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression multiple interactions |
ISO |
Indinavir results in decreased expression of ADIPOQ protein Indinavir results in decreased expression of ADIPOQ mRNA; Indinavir results in decreased expression of ADIPOQ protein diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of ADIPOQ protein]; Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of Deoxyglucose] |
CTD |
PMID:15865214 PMID:17668557 PMID:29991592 |
|
NCBI chr11:91,226,524...91,240,244
|
|
G |
Aebp1 |
AE binding protein 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of AEBP1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr14:80,738,800...80,748,878
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA |
CTD |
PMID:16931933 |
|
NCBI chr12:10,785,254...10,809,295
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
AGN 193109 inhibits the reaction [Indinavir promotes the reaction [Tretinoin results in increased expression of ALPL protein]]; Indinavir promotes the reaction [Tretinoin results in increased expression of ALPL protein] |
CTD |
PMID:10704935 |
|
NCBI chr 5:155,234,770...155,289,785
|
|
G |
Apob |
apolipoprotein B |
decreases secretion |
ISO |
Indinavir results in decreased secretion of APOB protein |
CTD |
PMID:32535746 |
|
NCBI chr 6:36,563,704...36,603,300
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases secretion decreases expression |
ISO |
Indinavir results in decreased secretion of APOC3 protein Indinavir results in decreased expression of APOC3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 8:46,531,478...46,533,658
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:112,034,636...112,199,273
|
|
G |
Asic2 |
acid sensing ion channel subunit 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:65,870,592...66,940,577
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:11706060 |
|
NCBI chr12:34,072,710...34,122,142
|
|
G |
C1r |
complement C1r |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C1R mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:157,412,718...157,423,483
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C3AR1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:156,074,747...156,084,680
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO |
Indinavir results in increased expression of CCL2 protein diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] |
CTD |
PMID:17668557 |
|
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
Indinavir results in increased expression of CCL3 protein |
CTD |
PMID:17668557 |
|
NCBI chr10:68,948,889...68,950,439
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CD36 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CIDEC mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:146,569,288...146,582,173
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CLCN3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr16:29,127,152...29,200,133
|
|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
Indinavir results in decreased expression of CRP protein |
CTD |
PMID:15622323 |
|
NCBI chr13:87,694,062...87,695,978
|
|
G |
Dcn |
decorin |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DCN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:34,167,973...34,208,004
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Indinavir results in increased expression of DDIT3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 7:65,001,695...65,006,517
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DUSP3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:86,920,014...86,933,739
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
Indinavir results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 4:104,363,838...104,425,271
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:244,997,287...245,001,115
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ESR2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ETV6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:166,849,031...167,085,211
|
|
G |
Fads2 |
fatty acid desaturase 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:206,707,384...206,747,333
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of FAIM mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:99,543,877...99,569,499
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions |
ISO |
Indinavir results in increased expression of FASN mRNA [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA |
CTD |
PMID:11741158 |
|
NCBI chr10:106,570,415...106,588,581
|
|
G |
G0s2 |
G0/G1switch 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr13:107,335,036...107,335,948
|
|
G |
Ganc |
glucosidase, alpha; neutral C |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of GANC mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 3:107,353,369...107,406,104
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:167,348,824...167,398,983
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of HADH mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:222,462,049...222,504,446
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of HCN1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:49,495,771...49,899,983
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of H4C9 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr17:47,176,246...47,180,690
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Indinavir results in increased expression of HSPA5 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 3:38,453,016...38,457,475
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:1,063,283...1,102,940
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of IL6 protein] |
CTD |
PMID:17668557 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Klhl28 |
kelch-like family member 28 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of KLHL28 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 6:88,723,624...88,755,072
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LAMC2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr13:67,835,199...67,894,694
|
|
G |
Lep |
leptin |
multiple interactions decreases expression |
ISO |
diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of LEP protein] [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LEP mRNA |
CTD |
PMID:16931933 PMID:17668557 |
|
NCBI chr 4:58,626,529...58,640,663
|
|
G |
Lpl |
lipoprotein lipase |
decreases activity multiple interactions increases expression |
ISO |
Indinavir results in decreased activity of LPL protein [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA Indinavir results in increased expression of LPL mRNA |
CTD |
PMID:11741158 PMID:11786383 |
|
NCBI chr16:25,596,205...25,621,928
|
|
G |
Me1 |
malic enzyme 1 |
multiple interactions |
ISO |
[Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA |
CTD |
PMID:11741158 |
|
NCBI chr 8:96,429,057...96,540,244
|
|
G |
Mgat4c |
MGAT4 family, member C |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MGAT4C mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:36,709,564...37,485,810
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 mRNA]; Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 protein]; Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP2 protein] |
CTD |
PMID:14662518 |
|
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] |
CTD |
PMID:14662518 |
|
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Mrap |
melanocortin 2 receptor accessory protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of MRAP mRNA |
CTD |
PMID:16931933 |
|
NCBI chr11:43,477,382...43,489,118
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
decreases expression |
ISO |
Indinavir results in decreased expression of MTTP mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 2:226,613,090...226,654,239
|
|
G |
Myod1 |
myogenic differentiation 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MYOD1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:106,021,161...106,023,871
|
|
G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NAP1L5 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:88,022,670...88,024,988
|
|
G |
Noct |
nocturnin |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:137,422,074...137,442,282
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA |
CTD |
PMID:11706060 |
|
NCBI chr 5:163,712,184...163,713,493
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
Indinavir results in increased expression of NRF1 mRNA |
CTD |
PMID:17926646 |
|
NCBI chr 4:58,664,932...58,772,328
|
|
G |
Nup210 |
nucleoporin 210 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:123,511,558...123,609,874
|
|
G |
Oaz3 |
ornithine decarboxylase antizyme 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OAZ3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:182,073,212...182,076,147
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
increases expression |
ISO |
Indinavir results in increased expression of P4HB mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:105,836,972...105,848,583
|
|
G |
Pcdh15 |
protocadherin related 15 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PCDH15 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:13,996,383...15,495,206
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PFKFB3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr17:71,893,320...71,974,526
|
|
G |
Phf6 |
PHD finger protein 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PHF6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr X:137,576,214...137,619,297
|
|
G |
Pidd1 |
p53-induced death domain protein 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIDD1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:205,966,392...205,972,359
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIWIL2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr15:45,431,402...45,498,034
|
|
G |
Porcn |
porcupine O-acyltransferase |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PPN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr X:14,285,864...14,298,481
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:3,227,836...3,232,598
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
Indinavir results in decreased expression of PPARG mRNA |
CTD |
PMID:17926646 |
|
NCBI chr 4:150,095,743...150,221,104
|
|
G |
Prdm1 |
PR/SET domain 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRDM1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:47,959,858...47,981,488
|
|
G |
Reep6 |
receptor accessory protein 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of REEP6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:9,373,927...9,380,845
|
|
G |
Rnf151 |
ring finger protein 151 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of RNF151 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:13,742,682...13,747,192
|
|
G |
Rpain |
RPA interacting protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of RPAIN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:56,190,975...56,198,490
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of S100A8 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:178,464,095...178,465,223
|
|
G |
Slc25a19 |
solute carrier family 25 member 19 |
multiple interactions |
ISO |
SLC25A19 protein affects the susceptibility to [Stavudine co-treated with Lamivudine co-treated with Indinavir]; SLC25A19 protein affects the susceptibility to [Zidovudine co-treated with Lamivudine co-treated with Indinavir] |
CTD |
PMID:15951836 |
|
NCBI chr10:100,853,554...100,867,517
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP |
[Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose] |
CTD |
PMID:18601907 |
|
NCBI chr10:55,164,721...55,170,289
|
|
G |
Spink5 |
serine peptidase inhibitor, Kazal type 5 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr18:36,264,452...36,333,143
|
|
G |
Tfap2a |
transcription factor AP-2 alpha |
decreases expression |
ISO |
Indinavir results in decreased expression of TFAP2A mRNA |
CTD |
PMID:17926646 |
|
NCBI chr17:24,230,064...24,253,219
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TIMP2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:104,041,604...104,089,214
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:15388451 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Trim42 |
tripartite motif-containing 42 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TRIM42 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:97,902,349...97,923,268
|
|
G |
Ucp1 |
uncoupling protein 1 |
decreases expression |
ISO |
Indinavir results in decreased expression of UCP1 mRNA |
CTD |
PMID:17926646 |
|
NCBI chr19:41,713,350...41,721,421
|
|
G |
Wnt10a |
Wnt family member 10A |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of WNT10A mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 9:76,349,931...76,362,400
|
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions |
ISO |
Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate] |
CTD |
PMID:20097249 |
|
NCBI chr19:30,046,494...30,085,039
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO EXP |
Perphenazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
CTD |
PMID:18493746 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression |
EXP |
Perphenazine results in decreased expression of FSHB protein |
CTD |
PMID:6770916 |
|
NCBI chr 3:114,003,262...114,007,072
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
ISO |
Perphenazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Perphenazine results in decreased activity of KCNH2 protein |
CTD |
PMID:21158687 PMID:28551711 |
|
NCBI chr 4:11,719,357...11,751,424
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression |
EXP |
Perphenazine results in decreased expression of LHB protein |
CTD |
PMID:6770916 |
|
NCBI chr 1:105,037,457...105,038,446
|
|
G |
Prl |
prolactin |
increases expression |
ISO EXP |
Perphenazine results in increased expression of PRL protein |
CTD |
PMID:6770916 PMID:7262630 PMID:17335319 |
|
NCBI chr17:38,287,355...38,298,234
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Perphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
|
|
G |
Tnni3 |
troponin I3, cardiac type |
increases expression |
ISO |
Perphenazine results in increased expression of TNNI3 protein |
CTD |
PMID:14742781 |
|
NCBI chr 1:78,342,571...78,346,255
|
|